|
000
| 02714nam 2200469zi 4500 |
|---|
| 001 | 9.908230 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240906104636 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 220217t20222022onc o f000 0 eng d |
|---|
| 020 | |a9780660421384 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 045 | |ay2y2 |
|---|
| 086 | 1 |aH21-313/2022E-PDF |
|---|
| 245 | 00|aFollow-up survey and qualitative research on opioid awareness, knowledge, and behaviours for public education (2021) : |bfinal report / |cprepared for Health Canada. |
|---|
| 246 | 17|aHealth Canada - follow-up survey and qualitative research on opioid awareness, knowledge, and behaviours for public education (2021) - research report |
|---|
| 264 | 1|aOttawa, Ontario : |bHealth Canada = Santé Canada, |c2022. |
|---|
| 264 | 4|c©2022 |
|---|
| 300 | |a1 online resource (137 pages) + |bsummary (9 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Enquête de suivi et recherche qualitative sur la sensibilisation, les connaissances et les comportements liés aux opioïdes aux fins de l'éducation du public (2021) : rapport final. |
|---|
| 500 | |a"Supplier name: Earnscliffe Strategy Group." |
|---|
| 500 | |a"Contract number: HT372-213980/001/CY." |
|---|
| 500 | |a"Delivery date: February 11, 2022." |
|---|
| 500 | |a"Registration number: POR 037-21." |
|---|
| 650 | 0|aOpioids|zCanada|xPublic opinion. |
|---|
| 650 | 0|aOpioid abuse|zCanada|xPublic opinion. |
|---|
| 650 | 0|aDrinking of alcoholic beverages|zCanada|xPublic opinion. |
|---|
| 650 | 0|aPublic opinion|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 710 | 2 |aEarnscliffe Strategy Group, |econsultant. |
|---|
| 775 | 08|tEnquête de suivi et recherche qualitative sur la sensibilisation, les connaissances et les comportements liés aux opioïdes aux fins de l'éducation du public (2021) : |w(CaOODSP)9.908231 |
|---|
| 856 | 40|qPDF|s2.04 MB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H21-313-2022-eng.pdf|z(final report) |
|---|
| 856 | 40|qPDF|s173 KB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H21-313-2022-1-eng.pdf|z(executive summary) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2022/037-21-e/POR037-21-Report-EN.html|z(final report) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2022/037-21-e/summary/POR037-21-Summary-EN.html|z(executive summary) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2022/037-21-e/index.html|z(complete dataset) |
|---|